Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare]—Global Forecast to 2031
The global medical gas and equipment market is projected to reach USD 30.05 billion by 2031 from USD 21.03 billion in 2025, at a CAGR of 6.2% during the forecast period.
The medical gas and equipment market is witnessing consistent growth. This is largely due to increased demand for respiratory care, critical care, and surgical procedures across healthcare systems worldwide. The rising prevalence of chronic diseases such as COPD, asthma, and cardiovascular disorders, along with a growing elderly population, has significantly increased dependence on medical gases and related delivery equipment. Moreover, the development and refurbishment of hospital buildings, ambulatory surgical centers, and home healthcare services, especially in developing countries, are leading to new medical gas infrastructure installations and upgrades. Furthermore, innovations in gas delivery systems, portable devices, and monitoring solutions are revolutionizing treatment efficiency and making care more accessible. Together, these factors are driving continued growth in the medical gas and equipment market.
“By type, the medical gases segment is expected to have the largest market share in the medical gas and equipment market.”
Medical gases represent the largest segment in the medical gas and equipment market by type, owing to their indispensable and constant use across nearly all healthcare settings. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide play a vital role in respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. While equipment is purchased or replaced on a one-time basis, medical gases are consumables that require a regular supply; hence, demand for them is consistently high. The escalating number of chronic disease cases, increasing surgical procedures, and rising hospital and ICU admissions continue to fuel medical gas consumption. Furthermore, the growth of home healthcare and long-term oxygen therapy, coupled with stringent regulatory requirements that guarantee uninterrupted gas availability in healthcare facilities, are among the reasons medical gases still hold the largest share of the overall medical gas and equipment market.
“By application, the therapeutic applications segment is expected to have the largest market share in the medical gas and equipment market.”
Therapeutic uses account for the largest share of the application segment in the medical gas and equipment market, as medical gases are of prime importance to the treatment and management of various acute and chronic conditions. Oxygen, nitrous oxide, and medical air are used in almost all cases of respiratory therapy, critical care, emergency medicine, anesthesia, and pain management, making them essential equipment in hospitals, clinics, and home care. With the rise in the number of people suffering from chronic respiratory and cardiovascular diseases, along with the increase in the elderly population, there has been a consequent demand for long-term, continuous therapeutic gas administration. In addition, more hospital admissions, higher surgical volumes, and the expanded use of home healthcare and long-term oxygen therapy further support the prominence of therapeutic applications. Consequently, the continuous, large-scale use of medical gases for patient treatment continues to drive the leading share of this segment in the medical gas and equipment market.
“The US is expected to grow at the highest CAGR for the North America medical gas and equipment market.”
The US market for medical gases and equipment is projected to have the highest CAGR in North America, driven by advanced healthcare infrastructure and high healthcare spending. Rising chronic respiratory and cardiovascular illnesses and an aging population are major factors behind substantial demand for medical gases such as oxygen and their delivery equipment. In addition, increased hospitalizations, growth in ICU facilities, and rising surgical volumes are accelerating the installation and upgrades of medical gas pipeline systems and equipment. The boom in home healthcare and the long-term oxygen therapy market, along with stringent patient safety regulations and compliance requirements, are propelling the market to grow faster. On top of that, ongoing technological progress and the presence of prominent medical gas manufacturers and service providers in the U.S. are helping the country maintain its position as the fastest-growing market in North America.
A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:
Research Coverage:
The report analyzes the medical gas and equipment market and aims to estimate the market size and future growth potential across various segments, including type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall medical gas and equipment market. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
The medical gas and equipment market is witnessing consistent growth. This is largely due to increased demand for respiratory care, critical care, and surgical procedures across healthcare systems worldwide. The rising prevalence of chronic diseases such as COPD, asthma, and cardiovascular disorders, along with a growing elderly population, has significantly increased dependence on medical gases and related delivery equipment. Moreover, the development and refurbishment of hospital buildings, ambulatory surgical centers, and home healthcare services, especially in developing countries, are leading to new medical gas infrastructure installations and upgrades. Furthermore, innovations in gas delivery systems, portable devices, and monitoring solutions are revolutionizing treatment efficiency and making care more accessible. Together, these factors are driving continued growth in the medical gas and equipment market.
“By type, the medical gases segment is expected to have the largest market share in the medical gas and equipment market.”
Medical gases represent the largest segment in the medical gas and equipment market by type, owing to their indispensable and constant use across nearly all healthcare settings. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide play a vital role in respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. While equipment is purchased or replaced on a one-time basis, medical gases are consumables that require a regular supply; hence, demand for them is consistently high. The escalating number of chronic disease cases, increasing surgical procedures, and rising hospital and ICU admissions continue to fuel medical gas consumption. Furthermore, the growth of home healthcare and long-term oxygen therapy, coupled with stringent regulatory requirements that guarantee uninterrupted gas availability in healthcare facilities, are among the reasons medical gases still hold the largest share of the overall medical gas and equipment market.
“By application, the therapeutic applications segment is expected to have the largest market share in the medical gas and equipment market.”
Therapeutic uses account for the largest share of the application segment in the medical gas and equipment market, as medical gases are of prime importance to the treatment and management of various acute and chronic conditions. Oxygen, nitrous oxide, and medical air are used in almost all cases of respiratory therapy, critical care, emergency medicine, anesthesia, and pain management, making them essential equipment in hospitals, clinics, and home care. With the rise in the number of people suffering from chronic respiratory and cardiovascular diseases, along with the increase in the elderly population, there has been a consequent demand for long-term, continuous therapeutic gas administration. In addition, more hospital admissions, higher surgical volumes, and the expanded use of home healthcare and long-term oxygen therapy further support the prominence of therapeutic applications. Consequently, the continuous, large-scale use of medical gases for patient treatment continues to drive the leading share of this segment in the medical gas and equipment market.
“The US is expected to grow at the highest CAGR for the North America medical gas and equipment market.”
The US market for medical gases and equipment is projected to have the highest CAGR in North America, driven by advanced healthcare infrastructure and high healthcare spending. Rising chronic respiratory and cardiovascular illnesses and an aging population are major factors behind substantial demand for medical gases such as oxygen and their delivery equipment. In addition, increased hospitalizations, growth in ICU facilities, and rising surgical volumes are accelerating the installation and upgrades of medical gas pipeline systems and equipment. The boom in home healthcare and the long-term oxygen therapy market, along with stringent patient safety regulations and compliance requirements, are propelling the market to grow faster. On top of that, ongoing technological progress and the presence of prominent medical gas manufacturers and service providers in the U.S. are helping the country maintain its position as the fastest-growing market in North America.
A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–45%, Director Level–35%, and Others–20%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .
Research Coverage:
The report analyzes the medical gas and equipment market and aims to estimate the market size and future growth potential across various segments, including type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall medical gas and equipment market. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (rising demand for medical oxygen, increasing number of surgeries, growing elderly population, and rising demand for home healthcare), restraints (declining reimbursements for respiratory therapies, and global helium shortage), opportunities (expansion of healthcare industry, rising demand for pain management, and advancements in healthcare technology) and challenges (limited availability of medical gases, and high cost of medical gas equipment).
- Market Penetration: It includes extensive information on products offered by the major players in the global the medical gas and equipment market. The report includes various segments in type, application, end user and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical gas and equipment market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the medical gas and equipment market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical gas and equipment market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW
3.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET
3.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX
3.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
3.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing demand for medical oxygen
4.2.1.2 Growing number of surgeries
4.2.1.3 Expansion of geriatric population and subsequent rise in chronic diseases
4.2.1.4 Shift toward home healthcare settings
4.2.2 RESTRAINTS
4.2.2.1 Declining reimbursements for respiratory therapies
4.2.2.2 Strict regulatory and safety compliance requirements
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion of healthcare industry
4.2.3.2 Surge in demand for pain management solutions
4.2.3.3 Growing advancements in healthcare technologies
4.2.4 CHALLENGES
4.2.4.1 Limited availability of medical gases
4.2.4.2 High cost of medical gas equipment
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY
5.2.4 TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT, BY REGION (2023–2025)
5.7 TRADE DATA ANALYSIS
5.7.1 IMPORT DATA
5.7.2 EXPORT DATA
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION
5.11.2 CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE
5.11.3 CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN
5.12 IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRY/REGION
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.4.4 Latin America
5.12.4.5 Middle East & Africa/GCC
5.12.5 IMPACT ON END USER INDUSTRIES
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 SMART MEDICAL GAS MONITORING SYSTEMS
6.1.2 AI-BASED PREDICTIVE MAINTENANCE
6.1.3 DIGITAL TWIN TECHNOLOGY
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 MEDICAL GAS PIPELINE SYSTEMS (MGPS)
6.3 ADJACENT TECHNOLOGIES
6.3.1 HEALTHCARE IOT (IOMT)
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.4.2 MID TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.4.3 LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.5 PATENT ANALYSIS
6.6 FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT
6.7 IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET
6.7.1 TOP USE CASES & MARKET POTENTIAL
6.7.2 BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE
9.1 INTRODUCTION
9.2 MEDICAL GASES
9.2.1 PURE MEDICAL GASES
9.2.1.1 Oxygen
9.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth
9.2.1.2 Carbon dioxide
9.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth
9.2.1.3 Nitrogen
9.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market
9.2.1.4 Nitrous oxide
9.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth
9.2.1.5 Medical air
9.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market
9.2.1.6 Other pure medical gases
9.2.2 MEDICAL GAS MIXTURES
9.2.2.1 Blood gas mixtures
9.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market
9.2.2.2 Lung diffusion mixtures
9.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth
9.2.2.3 Nitrous oxide-oxygen mixtures
9.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth
9.2.2.4 Carbon dioxide-oxygen mixtures
9.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market
9.2.2.5 Laser gas mixtures
9.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth
9.2.2.6 Anaerobic gas mixtures
9.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth
9.2.2.7 Aerobic gas mixtures
9.2.2.7.1 Booming geriatric population and rising pollution levels to drive market
9.2.2.8 Helium-oxygen mixtures
9.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth
9.2.2.9 Other medical gas mixtures
9.3 MEDICAL GAS EQUIPMENT
9.3.1 GAS DELIVERY SYSTEMS
9.3.1.1 Rising focus on patient stability and recovery to promote growth
9.3.2 GAS SUPPLY EQUIPMENT
9.3.2.1 Medical gas cylinders
9.3.2.1.1 Growing demand for portable oxygen delivery and emergency medical preparedness to propel market
9.3.2.2 Bulk storage systems
9.3.2.2.1 Rising healthcare infrastructure expansion and increasing medical gas consumption to propel market
9.3.2.3 Liquid oxygen systems
9.3.2.3.1 Increasing demand for high-volume oxygen supply and critical care services to propel market
9.3.2.4 Cryogenic tanks
9.3.2.4.1 Growing adoption of centralized medical gas storage and rising demand for large-capacity gas reserves to propel market
9.3.2.5 Vacuum systems
9.3.2.5.1 Growing focus on infection control and complex surgical therapies to propel market
9.3.2.6 Medical air compressors
9.3.2.6.1 Increasing demand for advanced healthcare services to augment growth
9.3.3 GAS REGULATION & MONITORING EQUIPMENT
9.3.3.1 Regulators
9.3.3.1.1 Rising focus on treatment efficacy and patient safety to augment growth
9.3.3.2 Flowmeters
9.3.3.2.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market
9.3.3.3 Valves with integrated pressure regulators (VIPRs)
9.3.3.3.1 Rising focus on improved patient care and streamlined operations to favor growth
9.3.3.4 Pressure gauges
9.3.3.4.1 Increasing emphasis on medical gas safety and real-time pressure monitoring to propel market
9.3.3.5 Gas monitoring systems
9.3.3.5.1 Need for safe and effective delivery of medical gases to aid growth
9.3.4 OTHER EQUIPMENT & ACCESSORIES
10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 THERAPEUTIC APPLICATIONS
10.2.1 RESPIRATORY THERAPIES
10.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market
10.2.2 CARDIOVASCULAR THERAPIES
10.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth
10.2.3 ANESTHESIA DELIVERY
10.2.3.1 Growing incidence of age-related health conditions to fuel market
10.2.4 CRYOSURGERY APPLICATIONS
10.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth
10.2.5 OTHER THERAPEUTIC APPLICATIONS
10.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS
10.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH
10.4 DIAGNOSTIC APPLICATIONS
10.4.1 MEDICAL IMAGING
10.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market
10.4.2 GENERAL LABORATORY APPLICATIONS
10.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market
10.5 OTHER APPLICATIONS
11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS & CLINICS
11.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH
11.3 HOME HEALTHCARE
11.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH
11.5 ACADEMIC & RESEARCH INSTITUTIONS
11.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET
11.6 OTHER END USERS
12 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Presence of key players to sustain growth
12.2.2 CANADA
12.2.2.1 Stringent regulatory compliance to favor market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Growing adoption of advanced healthcare technologies to fuel market
12.3.2 UK
12.3.2.1 Growing aging population to drive market
12.3.3 FRANCE
12.3.3.1 Well-established healthcare system to support growth
12.3.4 SPAIN
12.3.4.1 High burden of chronic diseases to augment growth
12.3.5 ITALY
12.3.5.1 Rising demand for therapeutic gases to aid growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 JAPAN
12.4.1.1 Dominant elderly population to propel market
12.4.2 CHINA
12.4.2.1 Strong public healthcare infrastructure to stimulate growth
12.4.3 INDIA
12.4.3.1 Growing incidence of cardiovascular diseases to spur growth
12.4.4 AUSTRALIA
12.4.4.1 Robust Medicare program to facilitate growth
12.4.5 SOUTH KOREA
12.4.5.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Increasing healthcare spending to contribute to market growth
12.5.2 MEXICO
12.5.2.1 Expanding pharmaceutical industry to propel market
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
12.6.2 GCC COUNTRIES
12.6.2.1 Increasing prevalence of cardiovascular diseases to augment growth
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 COMPANY VALUATION & FINANCIAL METRICS
13.8.1 FINANCIAL METRICS
13.8.2 COMPANY VALUATION
13.9 COMPETITIVE SCENARIO
13.9.1 DEALS
13.9.2 EXPANSIONS
13.9.3 THER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 LINDE PLC
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 AIR LIQUIDE
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 MESSER SE & CO. KGAA
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.3.2 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 AIR PRODUCTS AND CHEMICALS, INC.
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 NIPPON SANSO HOLDINGS CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Deals
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 ATLAS COPCO AB
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 GCE GROUP
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Deals
14.1.8 SOL SPA
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.8.3.2 Expansions
14.1.9 ROTAREX
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 NORCO INC.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 GENSTAR TECHNOLOGIES
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 SOUTHERN GAS LIMITED
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 DR?GERWERK AG & CO. KGAA
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 CALOX INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PT SAMATOR INDO GAS TBK
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 BUTLER GAS PRODUCTS COMPANY
14.2.2 AMICO GROUP OF COMPANIES
14.2.3 AIMS OXYGEN PVT LTD. (AOPL)
14.2.4 APEX MEDICAL GAS INC.
14.2.5 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
14.2.6 STEELMAN GASES PVT. LTD.
14.2.7 CARBIDE AND CHEMICALS
14.2.8 HOLSTON GASES
14.2.9 MEC MEDICAL LTD.
14.2.10 PRECISION UK
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.2 TOP-DOWN APPROACH
15.2.3 BASE NUMBER ESTIMATION
15.3 MARKET FORECAST APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 ASSUMPTIONS
15.5.1 MARKET SHARE ASSUMPTIONS
15.5.2 RESEARCH ASSUMPTIONS
15.6 FACTOR ANALYSIS
15.7 RISK ASSESSMENT
15.8 METHODOLOGY-RELATED LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW
3.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET
3.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX
3.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
3.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing demand for medical oxygen
4.2.1.2 Growing number of surgeries
4.2.1.3 Expansion of geriatric population and subsequent rise in chronic diseases
4.2.1.4 Shift toward home healthcare settings
4.2.2 RESTRAINTS
4.2.2.1 Declining reimbursements for respiratory therapies
4.2.2.2 Strict regulatory and safety compliance requirements
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion of healthcare industry
4.2.3.2 Surge in demand for pain management solutions
4.2.3.3 Growing advancements in healthcare technologies
4.2.4 CHALLENGES
4.2.4.1 Limited availability of medical gases
4.2.4.2 High cost of medical gas equipment
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY
5.2.4 TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT, BY REGION (2023–2025)
5.7 TRADE DATA ANALYSIS
5.7.1 IMPORT DATA
5.7.2 EXPORT DATA
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION
5.11.2 CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE
5.11.3 CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN
5.12 IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRY/REGION
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.4.4 Latin America
5.12.4.5 Middle East & Africa/GCC
5.12.5 IMPACT ON END USER INDUSTRIES
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 SMART MEDICAL GAS MONITORING SYSTEMS
6.1.2 AI-BASED PREDICTIVE MAINTENANCE
6.1.3 DIGITAL TWIN TECHNOLOGY
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 MEDICAL GAS PIPELINE SYSTEMS (MGPS)
6.3 ADJACENT TECHNOLOGIES
6.3.1 HEALTHCARE IOT (IOMT)
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.4.2 MID TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.4.3 LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.5 PATENT ANALYSIS
6.6 FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT
6.7 IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET
6.7.1 TOP USE CASES & MARKET POTENTIAL
6.7.2 BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE
9.1 INTRODUCTION
9.2 MEDICAL GASES
9.2.1 PURE MEDICAL GASES
9.2.1.1 Oxygen
9.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth
9.2.1.2 Carbon dioxide
9.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth
9.2.1.3 Nitrogen
9.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market
9.2.1.4 Nitrous oxide
9.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth
9.2.1.5 Medical air
9.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market
9.2.1.6 Other pure medical gases
9.2.2 MEDICAL GAS MIXTURES
9.2.2.1 Blood gas mixtures
9.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market
9.2.2.2 Lung diffusion mixtures
9.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth
9.2.2.3 Nitrous oxide-oxygen mixtures
9.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth
9.2.2.4 Carbon dioxide-oxygen mixtures
9.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market
9.2.2.5 Laser gas mixtures
9.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth
9.2.2.6 Anaerobic gas mixtures
9.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth
9.2.2.7 Aerobic gas mixtures
9.2.2.7.1 Booming geriatric population and rising pollution levels to drive market
9.2.2.8 Helium-oxygen mixtures
9.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth
9.2.2.9 Other medical gas mixtures
9.3 MEDICAL GAS EQUIPMENT
9.3.1 GAS DELIVERY SYSTEMS
9.3.1.1 Rising focus on patient stability and recovery to promote growth
9.3.2 GAS SUPPLY EQUIPMENT
9.3.2.1 Medical gas cylinders
9.3.2.1.1 Growing demand for portable oxygen delivery and emergency medical preparedness to propel market
9.3.2.2 Bulk storage systems
9.3.2.2.1 Rising healthcare infrastructure expansion and increasing medical gas consumption to propel market
9.3.2.3 Liquid oxygen systems
9.3.2.3.1 Increasing demand for high-volume oxygen supply and critical care services to propel market
9.3.2.4 Cryogenic tanks
9.3.2.4.1 Growing adoption of centralized medical gas storage and rising demand for large-capacity gas reserves to propel market
9.3.2.5 Vacuum systems
9.3.2.5.1 Growing focus on infection control and complex surgical therapies to propel market
9.3.2.6 Medical air compressors
9.3.2.6.1 Increasing demand for advanced healthcare services to augment growth
9.3.3 GAS REGULATION & MONITORING EQUIPMENT
9.3.3.1 Regulators
9.3.3.1.1 Rising focus on treatment efficacy and patient safety to augment growth
9.3.3.2 Flowmeters
9.3.3.2.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market
9.3.3.3 Valves with integrated pressure regulators (VIPRs)
9.3.3.3.1 Rising focus on improved patient care and streamlined operations to favor growth
9.3.3.4 Pressure gauges
9.3.3.4.1 Increasing emphasis on medical gas safety and real-time pressure monitoring to propel market
9.3.3.5 Gas monitoring systems
9.3.3.5.1 Need for safe and effective delivery of medical gases to aid growth
9.3.4 OTHER EQUIPMENT & ACCESSORIES
10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 THERAPEUTIC APPLICATIONS
10.2.1 RESPIRATORY THERAPIES
10.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market
10.2.2 CARDIOVASCULAR THERAPIES
10.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth
10.2.3 ANESTHESIA DELIVERY
10.2.3.1 Growing incidence of age-related health conditions to fuel market
10.2.4 CRYOSURGERY APPLICATIONS
10.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth
10.2.5 OTHER THERAPEUTIC APPLICATIONS
10.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS
10.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH
10.4 DIAGNOSTIC APPLICATIONS
10.4.1 MEDICAL IMAGING
10.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market
10.4.2 GENERAL LABORATORY APPLICATIONS
10.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market
10.5 OTHER APPLICATIONS
11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS & CLINICS
11.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH
11.3 HOME HEALTHCARE
11.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH
11.5 ACADEMIC & RESEARCH INSTITUTIONS
11.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET
11.6 OTHER END USERS
12 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Presence of key players to sustain growth
12.2.2 CANADA
12.2.2.1 Stringent regulatory compliance to favor market growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Growing adoption of advanced healthcare technologies to fuel market
12.3.2 UK
12.3.2.1 Growing aging population to drive market
12.3.3 FRANCE
12.3.3.1 Well-established healthcare system to support growth
12.3.4 SPAIN
12.3.4.1 High burden of chronic diseases to augment growth
12.3.5 ITALY
12.3.5.1 Rising demand for therapeutic gases to aid growth
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 JAPAN
12.4.1.1 Dominant elderly population to propel market
12.4.2 CHINA
12.4.2.1 Strong public healthcare infrastructure to stimulate growth
12.4.3 INDIA
12.4.3.1 Growing incidence of cardiovascular diseases to spur growth
12.4.4 AUSTRALIA
12.4.4.1 Robust Medicare program to facilitate growth
12.4.5 SOUTH KOREA
12.4.5.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Increasing healthcare spending to contribute to market growth
12.5.2 MEXICO
12.5.2.1 Expanding pharmaceutical industry to propel market
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
12.6.2 GCC COUNTRIES
12.6.2.1 Increasing prevalence of cardiovascular diseases to augment growth
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
13.3 REVENUE ANALYSIS, 2021–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Application footprint
13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 COMPANY VALUATION & FINANCIAL METRICS
13.8.1 FINANCIAL METRICS
13.8.2 COMPANY VALUATION
13.9 COMPETITIVE SCENARIO
13.9.1 DEALS
13.9.2 EXPANSIONS
13.9.3 THER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 LINDE PLC
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Expansions
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 AIR LIQUIDE
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 MESSER SE & CO. KGAA
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Deals
14.1.3.3.2 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 AIR PRODUCTS AND CHEMICALS, INC.
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 NIPPON SANSO HOLDINGS CORPORATION
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Deals
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses & competitive threats
14.1.6 ATLAS COPCO AB
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 GCE GROUP
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Deals
14.1.8 SOL SPA
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.8.3.2 Expansions
14.1.9 ROTAREX
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 NORCO INC.
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 GENSTAR TECHNOLOGIES
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 SOUTHERN GAS LIMITED
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 DR?GERWERK AG & CO. KGAA
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 CALOX INC.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 PT SAMATOR INDO GAS TBK
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 BUTLER GAS PRODUCTS COMPANY
14.2.2 AMICO GROUP OF COMPANIES
14.2.3 AIMS OXYGEN PVT LTD. (AOPL)
14.2.4 APEX MEDICAL GAS INC.
14.2.5 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
14.2.6 STEELMAN GASES PVT. LTD.
14.2.7 CARBIDE AND CHEMICALS
14.2.8 HOLSTON GASES
14.2.9 MEC MEDICAL LTD.
14.2.10 PRECISION UK
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.2 TOP-DOWN APPROACH
15.2.3 BASE NUMBER ESTIMATION
15.3 MARKET FORECAST APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 ASSUMPTIONS
15.5.1 MARKET SHARE ASSUMPTIONS
15.5.2 RESEARCH ASSUMPTIONS
15.6 FACTOR ANALYSIS
15.7 RISK ASSESSMENT
15.8 METHODOLOGY-RELATED LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 MEDICAL GAS AND EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 4 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER, 2023–2025 (USD MILLION)
TABLE 5 AVERAGE SELLING PRICE OF OXYGEN, BY REGION, 2023–2025 (USD)
TABLE 6 AVERAGE SELLING PRICE OF NITROUS OXIDE, BY REGION, 2023–2025 (USD)
TABLE 7 AVERAGE SELLING PRICE OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2023–2025 (USD)
TABLE 8 AVERAGE SELLING PRICE OF REGULATORS, BY REGION, 2023–2025 (USD)
TABLE 9 IMPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 10 EXPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 11 MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027)
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR MEDICAL GAS AND EQUIPMENT
TABLE 14 MEDICAL GAS AND EQUIPMENT MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 GLOBAL STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
TABLE 24 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
TABLE 25 MEDICAL GAS AND EQUIPMENT MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 26 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 27 MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 28 MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29 PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30 PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31 PURE MEDICAL GASES MARKET FOR OXYGEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OXYGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 33 PURE MEDICAL GASES MARKET FOR CARBON DIOXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR CARBON DIOXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 35 PURE MEDICAL GASES MARKET FOR NITROGEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 37 PURE MEDICAL GASES MARKET FOR NITROUS OXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROUS OXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 39 PURE MEDICAL GASES MARKET FOR MEDICAL AIR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR MEDICAL AIR, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 41 OTHER PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OTHER PURE MEDICAL GASES, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 43 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 44 MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 MEDICAL GAS MIXTURES MARKET FOR BLOOD GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 MEDICAL GAS MIXTURES MARKET FOR LUNG DIFFUSION MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 MEDICAL GAS MIXTURES MARKET FOR NITROUS OXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 MEDICAL GAS MIXTURES MARKET FOR CARBON DIOXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 MEDICAL GAS MIXTURES MARKET FOR LASER GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 MEDICAL GAS MIXTURES MARKET FOR ANAEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 MEDICAL GAS MIXTURES MARKET FOR AEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 MEDICAL GAS MIXTURES MARKET FOR HELIUM-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 OTHER MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 55 MEDICAL GAS EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 GAS DELIVERY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 GAS SUPPLY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL GAS CYLINDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 GAS SUPPLY EQUIPMENT MARKET FOR BULK STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 GAS SUPPLY EQUIPMENT MARKET FOR LIQUID OXYGEN SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 GAS SUPPLY EQUIPMENT MARKET FOR CRYOGENIC TANKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 GAS SUPPLY EQUIPMENT MARKET FOR VACUUM SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL AIR COMPRESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR REGULATORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR FLOWMETERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR PRESSURE GAUGES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR GAS MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER EQUIPMENT & ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 74 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 MEDICAL GAS AND EQUIPMENT MARKET FOR RESPIRATORY THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 MEDICAL GAS AND EQUIPMENT MARKET FOR CARDIOVASCULAR THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 MEDICAL GAS AND EQUIPMENT MARKET FOR ANESTHESIA DELIVERY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 MEDICAL GAS AND EQUIPMENT MARKET FOR CRYOSURGERY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL IMAGING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 MEDICAL GAS AND EQUIPMENT MARKET FOR GENERAL LABORATORY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 88 MEDICAL GAS AND EQUIPMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 MEDICAL GAS AND EQUIPMENT MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 MEDICAL GAS AND EQUIPMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97 NORTH AMERICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 98 NORTH AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99 NORTH AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 NORTH AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 106 US: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 US: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108 US: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109 US: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 US: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 US: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112 US: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 US: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 114 US: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 US: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 US: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 117 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 CANADA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 119 CANADA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 CANADA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121 CANADA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 CANADA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123 CANADA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 125 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 EUROPE: MARKET FOR PURE MEDICAL GASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 132 EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 137 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 140 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 GERMANY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 GERMANY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143 GERMANY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 GERMANY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145 GERMANY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 GERMANY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 151 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152 UK: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 UK: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 UK: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155 UK: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 UK: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 UK: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 159 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163 FRANCE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 FRANCE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 FRANCE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 FRANCE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 FRANCE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 FRANCE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 170 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 173 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 SPAIN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 SPAIN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 SPAIN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 SPAIN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 SPAIN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 SPAIN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 181 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 184 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 ITALY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 ITALY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ITALY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ITALY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 ITALY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190 ITALY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 192 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 REST OF EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 REST OF EUROPE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 REST OF EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 REST OF EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 REST OF EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 REST OF EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 203 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 ASIA PACIFIC: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 1 MEDICAL GAS AND EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 4 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER, 2023–2025 (USD MILLION)
TABLE 5 AVERAGE SELLING PRICE OF OXYGEN, BY REGION, 2023–2025 (USD)
TABLE 6 AVERAGE SELLING PRICE OF NITROUS OXIDE, BY REGION, 2023–2025 (USD)
TABLE 7 AVERAGE SELLING PRICE OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2023–2025 (USD)
TABLE 8 AVERAGE SELLING PRICE OF REGULATORS, BY REGION, 2023–2025 (USD)
TABLE 9 IMPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 10 EXPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 11 MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027)
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR MEDICAL GAS AND EQUIPMENT
TABLE 14 MEDICAL GAS AND EQUIPMENT MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 GLOBAL STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
TABLE 24 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
TABLE 25 MEDICAL GAS AND EQUIPMENT MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 26 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 27 MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 28 MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29 PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30 PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31 PURE MEDICAL GASES MARKET FOR OXYGEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OXYGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 33 PURE MEDICAL GASES MARKET FOR CARBON DIOXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR CARBON DIOXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 35 PURE MEDICAL GASES MARKET FOR NITROGEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 37 PURE MEDICAL GASES MARKET FOR NITROUS OXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROUS OXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 39 PURE MEDICAL GASES MARKET FOR MEDICAL AIR, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR MEDICAL AIR, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 41 OTHER PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OTHER PURE MEDICAL GASES, BY REGION, 2024–2031 (MILLION CUBIC METERS)
TABLE 43 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 44 MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 MEDICAL GAS MIXTURES MARKET FOR BLOOD GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 MEDICAL GAS MIXTURES MARKET FOR LUNG DIFFUSION MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 MEDICAL GAS MIXTURES MARKET FOR NITROUS OXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 MEDICAL GAS MIXTURES MARKET FOR CARBON DIOXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 MEDICAL GAS MIXTURES MARKET FOR LASER GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 MEDICAL GAS MIXTURES MARKET FOR ANAEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 MEDICAL GAS MIXTURES MARKET FOR AEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 MEDICAL GAS MIXTURES MARKET FOR HELIUM-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 OTHER MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 55 MEDICAL GAS EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 GAS DELIVERY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 GAS SUPPLY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL GAS CYLINDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 GAS SUPPLY EQUIPMENT MARKET FOR BULK STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 GAS SUPPLY EQUIPMENT MARKET FOR LIQUID OXYGEN SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 GAS SUPPLY EQUIPMENT MARKET FOR CRYOGENIC TANKS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 GAS SUPPLY EQUIPMENT MARKET FOR VACUUM SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL AIR COMPRESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR REGULATORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR FLOWMETERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR PRESSURE GAUGES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR GAS MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER EQUIPMENT & ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 74 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 MEDICAL GAS AND EQUIPMENT MARKET FOR RESPIRATORY THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 MEDICAL GAS AND EQUIPMENT MARKET FOR CARDIOVASCULAR THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 MEDICAL GAS AND EQUIPMENT MARKET FOR ANESTHESIA DELIVERY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 MEDICAL GAS AND EQUIPMENT MARKET FOR CRYOSURGERY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL IMAGING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85 MEDICAL GAS AND EQUIPMENT MARKET FOR GENERAL LABORATORY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 88 MEDICAL GAS AND EQUIPMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 MEDICAL GAS AND EQUIPMENT MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 MEDICAL GAS AND EQUIPMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 94 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97 NORTH AMERICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 98 NORTH AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99 NORTH AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 NORTH AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 106 US: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 US: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108 US: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109 US: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 US: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 US: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112 US: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 US: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 114 US: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 US: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 US: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 117 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 CANADA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 119 CANADA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 CANADA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121 CANADA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 CANADA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123 CANADA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 125 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 EUROPE: MARKET FOR PURE MEDICAL GASES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 132 EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 137 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 140 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 GERMANY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142 GERMANY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143 GERMANY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 GERMANY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145 GERMANY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 GERMANY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 151 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152 UK: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 UK: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 UK: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155 UK: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 UK: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 UK: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 159 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163 FRANCE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 FRANCE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 FRANCE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 FRANCE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 FRANCE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 FRANCE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 170 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 173 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174 SPAIN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 SPAIN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 SPAIN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 SPAIN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 SPAIN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 SPAIN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 181 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 184 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185 ITALY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 ITALY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ITALY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ITALY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 ITALY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190 ITALY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 192 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 REST OF EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 REST OF EUROPE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 REST OF EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 REST OF EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 REST OF EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 REST OF EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 203 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 ASIA PACIFIC: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 ASIA PACIFIC: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 MEDICAL GAS AND EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 MEDICAL GAS AND EQUIPMENT MARKET: YEARS CONSIDERED
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 4 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 5 PURE MEDICAL GASES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 6 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 7 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 8 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 9 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
FIGURE 11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
FIGURE 12 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 13 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 14 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 15 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 16 INCREASING HEALTHCARE EXPENDITURE AND PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
FIGURE 17 JAPAN AND MEDICAL GASES SEGMENT DOMINATED MARKET IN 2025
FIGURE 18 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 19 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 21 MEDICAL GAS AND EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030 (% OF TOTAL POPULATION)
FIGURE 23 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
FIGURE 24 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 25 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 26 MEDICAL GAS AND EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 MEDICAL GAS AND EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 MEDICAL GAS AND EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 29 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL GAS AND EQUIPMENT MARKET, 2020–2023
FIGURE 30 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL GAS AND EQUIPMENT MARKET (JANUARY 2016–MAY 2026)
FIGURE 31 TOP PATENT APPLICANT COUNTRIES FOR MEDICAL GAS AND EQUIPMENT (JANUARY 2016–MAY 2026)
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
FIGURE 34 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
FIGURE 35 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2021?2025)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2025)
FIGURE 38 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 39 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 40 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 41 MEDICAL GAS AND EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR
FIGURE 44 LINDE PLC: COMPANY SNAPSHOT (2025)
FIGURE 45 AIR LIQUIDE: COMPANY SNAPSHOT (2025)
FIGURE 46 MESSER SE & CO. KGAA: COMPANY SNAPSHOT (2025)
FIGURE 47 AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 49 ATLAS COPCO AB: COMPANY SNAPSHOT (2025)
FIGURE 50 SOL SPA: COMPANY SNAPSHOT (2025)
FIGURE 51 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2025)
FIGURE 52 DR?GERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025)
FIGURE 53 PT SAMATOR INDO GAS TBK: COMPANY SNAPSHOT (2025)
FIGURE 54 RESEARCH DESIGN
FIGURE 55 PRIMARY SOURCES
FIGURE 56 BOTTOM-UP APPROACH
FIGURE 57 TOP-DOWN APPROACH
FIGURE 58 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: LINDE PLC
FIGURE 60 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY-SIDE MARKET ESTIMATION (2025)
FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 62 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 1 MEDICAL GAS AND EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 MEDICAL GAS AND EQUIPMENT MARKET: YEARS CONSIDERED
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 4 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 5 PURE MEDICAL GASES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 6 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 7 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 8 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 9 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
FIGURE 10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
FIGURE 11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
FIGURE 12 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 13 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 14 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL GAS AND EQUIPMENT MARKET
FIGURE 15 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 16 INCREASING HEALTHCARE EXPENDITURE AND PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
FIGURE 17 JAPAN AND MEDICAL GASES SEGMENT DOMINATED MARKET IN 2025
FIGURE 18 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 19 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 21 MEDICAL GAS AND EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030 (% OF TOTAL POPULATION)
FIGURE 23 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
FIGURE 24 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 25 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 26 MEDICAL GAS AND EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 MEDICAL GAS AND EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 MEDICAL GAS AND EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 29 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL GAS AND EQUIPMENT MARKET, 2020–2023
FIGURE 30 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL GAS AND EQUIPMENT MARKET (JANUARY 2016–MAY 2026)
FIGURE 31 TOP PATENT APPLICANT COUNTRIES FOR MEDICAL GAS AND EQUIPMENT (JANUARY 2016–MAY 2026)
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
FIGURE 34 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
FIGURE 35 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2021?2025)
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2025)
FIGURE 38 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 39 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY FOOTPRINT
FIGURE 40 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 41 MEDICAL GAS AND EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR
FIGURE 44 LINDE PLC: COMPANY SNAPSHOT (2025)
FIGURE 45 AIR LIQUIDE: COMPANY SNAPSHOT (2025)
FIGURE 46 MESSER SE & CO. KGAA: COMPANY SNAPSHOT (2025)
FIGURE 47 AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 49 ATLAS COPCO AB: COMPANY SNAPSHOT (2025)
FIGURE 50 SOL SPA: COMPANY SNAPSHOT (2025)
FIGURE 51 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2025)
FIGURE 52 DR?GERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025)
FIGURE 53 PT SAMATOR INDO GAS TBK: COMPANY SNAPSHOT (2025)
FIGURE 54 RESEARCH DESIGN
FIGURE 55 PRIMARY SOURCES
FIGURE 56 BOTTOM-UP APPROACH
FIGURE 57 TOP-DOWN APPROACH
FIGURE 58 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: LINDE PLC
FIGURE 60 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY-SIDE MARKET ESTIMATION (2025)
FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 62 MARKET DATA TRIANGULATION METHODOLOGY
